Antiretrovirals calculated to extend life expectancy by 35 years
30 October 2008. Related: Antiretrovirals.
2008
Etravirine approved in Europe
30 October 2008. Related: Antiretrovirals.
Abacavir label updated in the US on use of B-5701 testing and cardiovascular risk
30 October 2008. Related: Antiretrovirals.
UK National Guidelines for HIV Testing 2008
30 October 2008. Related: Guidelines.
UK Guidelines on the Management of HIV infection in Pregnant Women (2008) published
30 October 2008. Related: Guidelines.
Ritonavir label updated in the US relating to cardiac arrhythmia reported in high-dose studies
30 October 2008. Related: Antiretrovirals, Side effects.
Atazanavir label updated in the US relating to drug interactions with NNTRIs, hormonal contraceptives, midazolam, H2 receptor antagonists and other drugs
30 October 2008. Related: Antiretrovirals.
Ugandan activists acquitted of trespass charges after objecting to exclusion of sexual minorities from the national HIV/AIDS programme
30 October 2008. Related: Other news.
UK Guidelines on HIV Associated Malignancies (2008) published online
30 October 2008. Related: Guidelines, BHIVA news.
US paediatric guidelines updated (2008)
30 October 2008. Related: Guidelines.
Implications of transmission with undetectable HIV viral load: lower limit for HIV transmission excluded from model
30 October 2008. Related: HIV prevention and transmission.
Tenofovir safe in pregnancy in macaque model
30 October 2008. Related: Pregnancy.
Microbial translocation in immunological non-responders to ART
30 October 2008. Related: Basic science and immunology, Vaccines and microbicides.
Case report of sexual transmission when viral load suppressed to <50 copies/mL
30 October 2008. Related: HIV prevention and transmission.
Atripla to be licensed in Latin America and the Asia-Pacific region
30 October 2008. Related: Treatment access.
HIV RNA is detectable in semen in 5% patients with undetectable blood plasma viral attending fertility clinic
30 October 2008. Related: HIV prevention and transmission.
Tenofovir gel as a rectal microbicide: evidence for protection and priming of T-cell responses in the SIV challenge model
30 October 2008. Related: HIV prevention and transmission.
Genetic protection against malaria may increase susceptibility to HIV infection in people of African decent
30 October 2008. Related: HIV prevention and transmission.
US CDC issue reports of false-positive oral rapid tests in New York HIV testing programme
30 October 2008. Related: HIV prevention and transmission.
Drug interaction reports from Liverpool University website
30 October 2008. Related: PK and drug interactions.
FDA approval of generic ARVs
24 October 2008. Related: Treatment access.
IAVI Report
8 October 2008. Related: On the web.
In defence of rational AIDS activism: how the irrationality of Act Up-Paris and others is risking the health of people with HIV or at risk of HIV infection
8 October 2008. Related: On the web.
Conference abstracts and presentations
8 October 2008. Related: On the web.
Latest global and country-level HIV/AIDS data
8 October 2008. Related: On the web.
PRN notebook articles
8 October 2008. Related: On the web.
PEPFAR funding bill authorised by the US Senate
8 October 2008. Related: Treatment access.
PLoS Medicine articles
8 October 2008. Related: On the web.
Mexico 2008: non-technical summary of 10 key areas of research PDF
1 October 2008. Related: PDFs.
10 key areas of research: non-technical summary of studies and presentations from Mexico
1 October 2008. Related: Special reports, Conference reports.
Volume 9 Number 9/10 Sep/Oct 2008 PDF
1 October 2008. Related: PDFs.
Volume 9 Number 7/8 Jul/Aug 2008
30 August 2008. Related: Editorial.
XVII International HIV Resistance Workshop (IHDRW), 6-10 June 2008, Sitges
30 August 2008. Related: Conference reports.
Integrase inhibitor resistance and cross-resistance: weighing viral fitness and the option to benefit from second-generation compounds
30 August 2008. Related: Conference reports, Drug resistance.
Understanding etravirine susceptibility: new weighted genotype score and phenotypic cut-offs
30 August 2008. Related: Conference reports, Drug resistance.
Pipeline antiretrovirals: IDX899, CHX157 and bevirimat
30 August 2008. Related: Conference reports, Antiretrovirals.
Lack of virological impact of treatment intensification in suppressed patients supports latent viral reservoir as source of residual viraemia
30 August 2008. Related: Conference reports, Drug resistance.
NNRTI resistance in infants prophylaxed with single-dose nevirapine varies by the timing of infection
30 August 2008. Related: Conference reports, Drug resistance.
Detecting viral tropism: impact of a more sensitive Trofile (ES) assay
30 August 2008. Related: Conference reports, Drug resistance.
Low frequency K103N mutations are associated with poor virological response to NNRTI based therapy
30 August 2008. Related: Conference reports, Drug resistance.
14th Annual BHIVA Conference, 23-25 April 2008, Belfast
30 August 2008. Related: Conference reports.
Bone problems raised in several UK studies
30 August 2008. Related: Conference reports, Side effects.
Late diagnosis in adolescence of vertically acquired HIV infection
30 August 2008. Related: Conference reports, Paediatric care.
Case study of multi-drug resistant woman receiving newer antiretroviral drugs in pregnancy
30 August 2008. Related: Conference reports, Pregnancy.
Predictors of treatment failure in Western Cape, South Africa
30 August 2008. Related: Conference reports.
Late pregnancy loss in HIV-positive women
30 August 2008. Related: Conference reports, Pregnancy.
Renal tubular dysfunction with tenofovir-based HAART in four vertically infected adolescents
30 August 2008. Related: Conference reports, Antiretrovirals.
15th Conference on Retroviruses and Opportunistic Infections, Boston, 2-6 February 2008
30 August 2008. Related: Conference reports.
The unmet need for contraception services for women receiving ART
30 August 2008. Related: Conference reports, Women's health.
Valacyclovir decreases plasma and genital viral loads in HSV-2/HIV-1 co-infected women
30 August 2008. Related: Conference reports, Women's health.
HPV genotypes in HIV-positive women in Zimbabwe and Uganda
30 August 2008. Related: Conference reports, Women's health.
FDA approval of generic ARVs
30 August 2008. Related: Treatment access.
Access to generic efavirenz in South Africa: MSD agrees to grant licenses on reasonable terms
30 August 2008. Related: Treatment access.
Reaching 3 by 5…by 7: new report on universal access
30 August 2008. Related: Treatment access.
Oxfam criticises DFID’s new strategy as a “missed opportunity”
30 August 2008. Related: Treatment access.
Boosted atazanavir approved in Europe as first-line therapy
30 August 2008. Related: Antiretrovirals.
BMS and Merck discontinue 100mg capsule formulation of efavirenz used for paediatric treatment
30 August 2008. Related: Antiretrovirals.
Saquinavir (Invirase) interactions with digoxin, garlic capsules, methadone, tipranavir and omeprazole: US label changes
30 August 2008. Related: Antiretrovirals.
US label changes for nevirapine paediatric solution
30 August 2008. Related: Antiretrovirals.
New US pediatric dosing for lopinavir/r
30 August 2008. Related: Antiretrovirals.
New US pediatric dosing for tipranavir/r
30 August 2008. Related: Antiretrovirals.
DSMB stops ACTG study due to suboptimal responses
30 August 2008. Related: Antiretrovirals.
UK (BHIVA) 2008 Treatment Guidelines published online
29 August 2008. Related: Guidelines, BHIVA news.
Major updates to US guidelines on prevention and treatment of OIs (2008)
29 August 2008. Related: Guidelines.
Low rates of MTCT in UK and Ireland
29 August 2008. Related: Pregnancy.